ADDARIO LUNG CANCER MEDICAL INSTITUTE
🇺🇸United States
Clinical Trials
10
Active:0
Completed:2
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
An Observational Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
Not yet recruiting
- Conditions
- Small Cell Lung Cancer ( SCLC )Lambert Eaton Myasthenic Syndrome (LEMS)
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 400
- Registration Number
- NCT07075627
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Recruiting
- Conditions
- Small-cell Lung Cancer
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06486428
- Locations
- 🇺🇸
Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html, Multiple Locations, Wyoming, United States
🇺🇸Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Studying Pathways of Resistance in KRAS-driven Cancers
Recruiting
- Conditions
- KRAS P.G12C
- First Posted Date
- 2022-03-09
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 500
- Registration Number
- NCT05272423
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy
Terminated
- Conditions
- NSCLC, Stage IIICNSCLC Stage IV
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 29
- Registration Number
- NCT04676386
- Locations
- 🇺🇸
Addario Lung Cancer Medical Institute (ALCMI), San Carlos, California, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
Epidemiology of Young Lung Cancer - Survey
Recruiting
- Conditions
- NSCLC
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 250
- Registration Number
- NCT04640259
- Locations
- 🇺🇸
USC Keck School of Medicine, Los Angeles, California, United States
🇺🇸Addario Lung Cancer Medical Institute, San Carlos, California, United States
- Prev
- 1
- 2
- Next
News
No news found